HIV/AIDS News

  • Home
  • HIV/AIDS News
  • Nominations for New Members for the Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission in the U.S.

Nominations for New Members for the Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission in the U.S.

Date: August 11, 2016
Source: AIDSinfo

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission in the U.S. (the Perinatal Guidelines Panel) is accepting nominations for new scientific/clinical members with expertise in HIV in pregnant women and perinatal transmission. The Panel is seeking candidates with expertise in obstetrics/gynecology, pharmacology, pediatrics, and infectious disease studies in pregnant women.

Panel members critically evaluate new information and prepare guidelines revisions. The candidates shall be recognized experts in their areas of interest with a record of publications and presentations. The successful candidates shall serve a three-year term beginning October 2016, with potential for reappointment. Because these are guidelines focused on management of HIV-infected pregnant women and perinatal transmission within the United States, candidates should be from the United States.

The Perinatal Guidelines Panel is a Working Group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health (NIH). The Panel is comprised of approximately 30 members who are clinicians, researchers, academicians, and HHS representatives with expertise in management of pregnant HIV-infected women (with training in either obstetrician/gynecologists or women’s health, or nursing with expertise in women’s health) and interventions for perinatal transmission (such as pediatric specialists in HIV infection), as well as community representatives with knowledge of HIV infection in pregnant women and interventions for perinatal transmission.

The Panel meets monthly via teleconferencing to review and critically evaluate emerging scientific data relating to antiretroviral therapy in pregnant women and interventions for perinatal transmission to update of the “Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States”, which is found at https://AIDSinfo.nih.gov.

Panel members are not compensated for their time commitment.

The nomination should include a curriculum vitae and a letter of nomination or letter of interest with specific reference to how the nominee would contribute to the work of the Panel. Please submit nominations to Angie Landenburger, AIDSinfo Guidelines Coordinator, at angie.landenburger@icfi.com. We are requesting that nominations be submitted by September 16, 2016.